[HTML][HTML] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 1: a guide to decision …
FC Detterbeck, JD Blasberg, GA Woodard… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options (lobectomy, segmentectomy, wedge, Stereotactic Body …
involves multiple options (lobectomy, segmentectomy, wedge, Stereotactic Body …
[HTML][HTML] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of …
FC Detterbeck, VJ Mase Jr, AX Li… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options (lobectomy, segmentectomy, wedge, stereotactic body …
involves multiple options (lobectomy, segmentectomy, wedge, stereotactic body …
Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases
K Suda, T Mitsudomi, Y Shintani, J Okami, H Ito… - The Annals of thoracic …, 2021 - Elsevier
Background To elucidate the clinical, pathologic, and prognostic impacts of epidermal
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …
A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy
Lung cancer, the leading cause of cancer death worldwide, is most frequently detected
through imaging tests. In this study, we investigated serum microRNAs (miRNAs) as a …
through imaging tests. In this study, we investigated serum microRNAs (miRNAs) as a …
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors
F Shoji, H Takeoka, Y Kozuma, G Toyokawa… - Lung Cancer, 2019 - Elsevier
Abstract Objectives Immune checkpoint inhibitors (ICIs) have been established as a novel
strategy for non-small cell lung cancer (NSCLC) therapy. However, a definitive biomarker …
strategy for non-small cell lung cancer (NSCLC) therapy. However, a definitive biomarker …
Randomized phase III study of pemetrexed plus cisplatin versus vinorelbine plus cisplatin for completely resected stage II to IIIA nonsquamous non–small-cell lung …
H Kenmotsu, N Yamamoto, T Yamanaka… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To evaluate the efficacy of pemetrexed plus cisplatin versus vinorelbine plus
cisplatin as postoperative adjuvant chemotherapy in patients with pathologic stage II-IIIA …
cisplatin as postoperative adjuvant chemotherapy in patients with pathologic stage II-IIIA …
Development of artificial intelligence prognostic model for surgically resected non-small cell lung cancer
F Kinoshita, T Takenaka, T Yamashita, K Matsumoto… - Scientific reports, 2023 - nature.com
There are great expectations for artificial intelligence (AI) in medicine. We aimed to develop
an AI prognostic model for surgically resected non-small cell lung cancer (NSCLC). This …
an AI prognostic model for surgically resected non-small cell lung cancer (NSCLC). This …
[HTML][HTML] Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
S Ohara, K Suda, K Sakai, M Nishino… - … lung cancer research, 2020 - ncbi.nlm.nih.gov
Background Recent studies of advanced lung cancer patients have shown that circulating
tumor DNA (ctDNA) analysis is useful for molecular profiling, monitoring tumor burden, and …
tumor DNA (ctDNA) analysis is useful for molecular profiling, monitoring tumor burden, and …
Bidirectional Mendelian randomization analysis of the genetic association between primary lung cancer and colorectal cancer
Z Xiao, Z Wang, T Zhang, Y Liu, M Si - Journal of translational medicine, 2023 - Springer
Background With the development and popularization of low-dose chest CT technology, the
diagnosis and survival rates of patients with early lung cancer (LC) have significantly …
diagnosis and survival rates of patients with early lung cancer (LC) have significantly …
Survival of octogenarians with early-stage non-small cell lung cancer is comparable between wedge resection and lobectomy/segmentectomy: JACS1303
T Mimae, H Saji, H Nakamura, N Okumura… - Annals of Surgical …, 2021 - Springer
Background Anatomic resection with lymph node dissection or sampling is the standard
treatment for early non-small cell lung cancer (NSCLC), and wedge resection is an option for …
treatment for early non-small cell lung cancer (NSCLC), and wedge resection is an option for …